Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Brain connexins in demyelinating diseases: Therapeutic potential of glial targets.
Novel cerebrospinal fluid and serum autoantibody targets for Clinically Isolated Syndrome.
Multiple sclerosis simulating brain tumor.
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Effects of Intermittent Versus Continuous Walking on Distance Walked and Fatigue in Persons With Multiple Sclerosis: A Randomized Crossover Trial.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Aquaporin-4 autoimmunity.
The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
The effect of triiodothyronine on maturation and differentiation of oligodendrocyte progenitor cells during remyelination following induced demyelination in male albino rat.
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
[Vitamin D in Multiple Sclerosis].
Pages
« first
‹ previous
…
474
475
476
477
478
479
480
481
482
…
next ›
last »